CW
CRSP icon

CreativeOne Wealth’s CRISPR Therapeutics CRSP Stock Holding History

CreativeOne Wealth’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,234
Closed -$222K – 1192
2025
Q4 		$222K Buy
+4,234
New +$254K 0.01% 1079
2025
Q3 		– Sell
-4,775
Closed -$232K – 1158
2025
Q2 		$232K Buy
+4,775
New +$185K 0.01% 1011
2021
Q4 		– Sell
-1,962
Closed -$220K – 756
2021
Q3 		$220K Hold
1,962
– – 0.01% 642
2021
Q2 		$318K Sell
1,962
-5,785
-75% -$704K 0.02% 516
2021
Q1 		$944K Buy
7,747
+1,239
+19% +$187K 0.07% 213
2020
Q4 		$996K Buy
+6,508
New +$769K 0.08% 186

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GP
GSK plc London $599M AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return